Evofem Biosciences, Inc.
EVFM
$0.01
$0.002.27%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 104.41% | 31.54% | -110.31% | -106.13% | -116.72% |
| Total Depreciation and Amortization | -20.18% | 85.37% | 493.13% | 501.88% | 36.06% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -200.72% | -20.08% | 97.67% | 92.77% | 105.15% |
| Change in Net Operating Assets | -32.76% | -69.38% | -73.37% | -66.26% | -81.66% |
| Cash from Operations | 48.73% | -169.03% | -47.13% | 11.70% | 56.68% |
| Capital Expenditure | 64.29% | 85.71% | 85.71% | 100.00% | -250.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 188.80% | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 89.73% | -- | -- | -- | -- |
| Cash from Investing | 89.10% | 79.92% | -4,285.71% | -3,980.00% | -14,125.00% |
| Total Debt Issued | 607.30% | 262.32% | -27.98% | -90.08% | -92.96% |
| Total Debt Repaid | -15.73% | -33.63% | 35.18% | 20.54% | 32.24% |
| Issuance of Common Stock | -- | 4,210.34% | 3,746.15% | 2,083.41% | 1,624.14% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -200.00% | -200.00% | -- | -- |
| Cash from Financing | -59.02% | 87.51% | 62.78% | 45.69% | -3.37% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -201.24% | -62.18% | 0.00% | 149.70% | 103.84% |